newsfilter
← Latest News
FDA Approved Drugs·

Approval of Pluvicto, Nda #215833 (Labeling)

Approval Date: 04/07/2026; Drug Name: Pluvicto, Nda #215833; Active Ingredients: LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN; Company: Novartis; Submission Status: Approval; Submission Classification: Labeling; Application Number: 215833

Company
NOVARTIS
Keywords
NOVARTIS